LDLR p.Val436Ala
Variant summary
The NM_000527.5(LDLR):c.1307T>C (p.Val436Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000806 (AC=13) in the gnomAD database across 1,613,722 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004087471: A functional study detected partial reduction of LDLR protein expression in cells derived from a patient heterozygous for this alteration" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.V436E: Likely_pathogenic (ClinVar VariationId 1518023, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V436M: Uncertain_significance (ClinVar VariationId 1172265, 1 star)
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Natera
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 15 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV004087471: A functional study detected partial reduction of LDLR protein expression in cells derived from a patient heterozygous for this alteration; however, the clinical significance of the observed decrease is unclear (Selberg O et al. J Appl Res., 2003;3:495-504). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 33 pathogenic, 0 benign (OR vs. background: 335.0). | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000488 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.V436E: Likely_pathogenic (ClinVar VariationId 1518023, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.V436M: Uncertain_significance (ClinVar VariationId 1172265, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (16/17 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
LDLR | MANE Select | c.1307T>C p.Val436Ala | missense | Exon 9 of 18 | Prot: NP_000518.1 UniProt: | |
LDLR | c.1307T>C p.Val436Ala | missense | Exon 9 of 18 | Prot: NP_001182727.1 UniProt: | ||
LDLR | c.1184T>C p.Val395Ala | missense | Exon 8 of 17 | Prot: NP_001182728.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
LDLR | TSL:1MANE Select | c.1307T>C p.Val436Ala | missense | Exon 9 of 18 | Prot: ENSP00000454071.1 UniProt: | |
LDLR | TSL:1 | c.1565T>C p.Val522Ala | missense | Exon 9 of 18 | Prot: ENSP00000252444.6 UniProt: | |
LDLR | TSL:1 | c.1307T>C p.Val436Ala | missense | Exon 9 of 18 | Prot: ENSP00000453346.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000132 | AC:2 | Hom:0 | AN:152042 | Cov:29 |
GnomAD2 exomes | AF: 0.0000119 | AC:3 | AN:251266 | ||
GnomAD4 exome | AF: 0.00000753 | AC:11 | Hom:0 | AN:1461680 | Cov:33 |
GnomAD4 genome | AF: 0.0000132 | AC:2 | Hom:0 | AN:152042 | Cov:29 |
TOPMed (Bravo) | AF: 0.00000378 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000377 | AC:2 | Hom:0 | AN:53064 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.0000238 | 1 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.0000144 | 1 | 69396 | 0.00000802 | 1 | 124680 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 22 | |
AlphaMissense | Benign | 0.17 | |
BayesDel_addAF | Pathogenic | 0.28 | D |
BayesDel_noAF | Pathogenic | 0.23 | |
CADD | Pathogenic | 27 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.75 | D |
Eigen | Benign | 0.18 | |
Eigen_PC | Uncertain | 0.27 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 0.55 | |
GPN-Star LLR | N/A | -6.9 | |
GPN-Star score | N/A | 6.9 | |
LIST_S2 | Benign | 0.81 | T |
M_CAP | Pathogenic | 0.61 | D |
MetaRNN | Pathogenic | 0.92 | D |
MetaSVM | Uncertain | 0.59 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Benign | 1.2 | L |
PhyloP100 | Uncertain | 6.1 | |
popEVE | Benign | -3.2 | |
PrimateAI | Uncertain | 0.51 | T |
PROVEAN | Uncertain | -3.6 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.1 | |
REVEL | Pathogenic | 0.75 | |
Sift | Uncertain | 0.0020 | D |
Sift4G | Uncertain | 0.0090 | D |
Varity_R | N/A | 0.62 | |
VESM-3B | Benign | -7.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- LDLR
- Assay type
- Flow cytometry assay
- Mechanism
- Gain or loss of function
- Model system
- Immortalized human cells
- Score
- 0.926 · p.Val436Ala (assay numbering)